Literature DB >> 21241758

miRNA and vascular cell movement.

Junming Yue1.   

Abstract

miRNAs are a new class of endogenous small RNAs that negatively regulate gene expression at the posttranscriptional level. Accumulating experimental evidence shows that miRNAs regulate cellular apoptosis, proliferation, differentiation, and migration. Dysregulation of miRNA expression leads to various human diseases including cancer and cardiovascular disease. miRNA maturation is regulated at multiple steps by different mechanisms, including miRNA editing, hairpin loop binding, self-regulation, and cross-talk with other signaling pathways. Vascular cell movement plays a pivotal role in the development of various cancers and cardiovascular diseases. miRNAs have been found to regulate vascular cell movement. Presently the chemically synthesized antagomir and miRNA mimics have been widely used in investigating the biological functions of miRNA genes. The viral vectors, including adenoviral, lentiviral, and adeno-associated viral vectors, have been used to efficiently overexpress or knockdown miRNAs in vitro and in vivo. Therefore, targeting vascular cell movement using miRNA-based drug or gene therapy would provide a novel therapeutic approach in the treatment of cancers and vascular diseases.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21241758      PMCID: PMC3129380          DOI: 10.1016/j.addr.2011.01.001

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  90 in total

1.  Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans.

Authors:  Tianrun Li; Hengchang Cao; Jinman Zhuang; Jun Wan; Ming Guan; Bo Yu; Xuan Li; Wei Zhang
Journal:  Clin Chim Acta       Date:  2010-09-29       Impact factor: 3.786

Review 2.  Emerging complexity of microRNA generation cascades.

Authors:  Hiroshi I Suzuki; Kohei Miyazono
Journal:  J Biochem       Date:  2010-09-27       Impact factor: 3.387

3.  Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis.

Authors:  Angelika Kuehbacher; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circ Res       Date:  2007-05-31       Impact factor: 17.367

4.  Conservation of miR-15a/16-1 and miR-15b/16-2 clusters.

Authors:  Junming Yue; Gabor Tigyi
Journal:  Mamm Genome       Date:  2009-12-16       Impact factor: 2.957

5.  miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.

Authors:  Lin Xia; Dexin Zhang; Rui Du; Yanglin Pan; Lina Zhao; Shiren Sun; Liu Hong; Jie Liu; Daiming Fan
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

6.  Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis.

Authors:  Satoshi Asada; Tomosaburo Takahashi; Koji Isodono; Atsuo Adachi; Hiroko Imoto; Takehiro Ogata; Tomomi Ueyama; Hiroaki Matsubara; Hidemasa Oh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-31       Impact factor: 4.733

7.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

8.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

9.  The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs.

Authors:  Michele Trabucchi; Paola Briata; Mariaflor Garcia-Mayoral; Astrid D Haase; Witold Filipowicz; Andres Ramos; Roberto Gherzi; Michael G Rosenfeld
Journal:  Nature       Date:  2009-05-20       Impact factor: 49.962

10.  Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis.

Authors:  Coen van Solingen; Leonard Seghers; Roel Bijkerk; Jacques M G J Duijs; Marko K Roeten; Annemarie M van Oeveren-Rietdijk; Hans J Baelde; Matthieu Monge; Joost B Vos; Hetty C de Boer; Paul H A Quax; Ton J Rabelink; Anton Jan van Zonneveld
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.310

View more
  10 in total

1.  Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?

Authors:  Christopher J Donnelly; Jonathan C Grima; Rita Sattler
Journal:  Neurodegener Dis Manag       Date:  2014

2.  DiGeorge syndrome critical region 8 (DGCR8) protein-mediated microRNA biogenesis is essential for vascular smooth muscle cell development in mice.

Authors:  Zixuan Chen; Jianmin Wu; Chuanhe Yang; Pei Fan; Louisa Balazs; Yan Jiao; Meifeng Lu; Weikuan Gu; Chengyao Li; Lawrence M Pfeffer; Gabor Tigyi; Junming Yue
Journal:  J Biol Chem       Date:  2012-04-17       Impact factor: 5.157

3.  Construction of lentivirus-based inhibitor of hsa-microRNA-338-3p with specific secondary structure.

Authors:  Kai Sun; Chen Guo; Hai-jun Deng; Jing-qing Dong; Shang-tong Lei; Guo-xin Li
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

Review 4.  MicroRNAs as therapeutic targets in breast cancer metastasis.

Authors:  Fahima Danesh Pouya; Yousef Rasmi; Maria Gazouli; Eleni Zografos; Mohadeseh Nemati
Journal:  Drug Deliv Transl Res       Date:  2021-05-13       Impact factor: 4.617

Review 5.  Novel insights into miRNA in lung and heart inflammatory diseases.

Authors:  Amit Kishore; Jana Borucka; Jana Petrkova; Martin Petrek
Journal:  Mediators Inflamm       Date:  2014-05-27       Impact factor: 4.711

6.  An Assessment of Database-Validated microRNA Target Genes in Normal Colonic Mucosa: Implications for Pathway Analysis.

Authors:  Martha L Slattery; Jennifer S Herrick; John R Stevens; Roger K Wolff; Lila E Mullany
Journal:  Cancer Inform       Date:  2017-06-23

Review 7.  Opportunities Offered by Graphene Nanoparticles for MicroRNAs Delivery for Amyotrophic Lateral Sclerosis Treatment.

Authors:  Benedetta Niccolini; Valentina Palmieri; Marco De Spirito; Massimiliano Papi
Journal:  Materials (Basel)       Date:  2021-12-24       Impact factor: 3.623

Review 8.  Role of miRNAs in vascular development.

Authors:  Albert Sufianov; Sema Begliarzade; Valentin Kudriashov; Radmila Nafikova; Tatiana Ilyasova; Yanchao Liang
Journal:  Noncoding RNA Res       Date:  2022-09-29

9.  miRNA biogenesis enzyme Drosha is required for vascular smooth muscle cell survival.

Authors:  Pei Fan; Zixuan Chen; Peng Tian; Wen Liu; Yan Jiao; Yi Xue; Anindya Bhattacharya; Jianmin Wu; Meifen Lu; Yuqi Guo; Yan Cui; Weikuan Gu; Weiwang Gu; Junming Yue
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

10.  Delivery of nucleic acid therapeutics for cancer immunotherapy.

Authors:  Shurong Zhou; Wenjie Chen; Janet Cole; Guizhi Zhu
Journal:  Med Drug Discov       Date:  2020-03-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.